Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Novel Physiotherapies received 2500 citations as per Google Scholar report
Neuropsychiatric drugs are medications designed to treat disorders that affect both neurological and psychiatric functions. These drugs are used to manage a variety of conditions, including depression, anxiety, schizophrenia, bipolar disorder, and neurodegenerative diseases. They work by targeting neurotransmitter systems in the brain, which play a crucial role in regulating mood, cognition, and behavior. For instance, antidepressants such as Selective Serotonin Reuptake Inhibitors (SSRIs) enhance serotonin levels to improve mood, while antipsychotics can modulate dopamine activity to manage symptoms of psychosis. The development and use of neuropsychiatric drugs require careful consideration of efficacy, side effects, and interactions with other medications. Ongoing research aims to refine these treatments, enhance their effectiveness, and minimize adverse effects, with the ultimate goal of improving mental health outcomes and quality of life for individuals with complex neuropsychiatric conditions.